Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [1] Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction
    Malik, Awais
    Gill, Gauravpal S.
    Lodhi, Fahad K.
    Tummala, Lakshmi S.
    Singh, Steven N.
    Morgan, Charity J.
    Allman, Richard M.
    Fonarow, Gregg C.
    Ahmed, Ali
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (01): : 84 - 94
  • [2] Stroke in patients with heart failure and reduced or preserved ejection fraction
    Yang, Mingming
    Kondo, Toru
    Butt, Jawad H.
    Abraham, William T.
    Anand, Inder S.
    Desai, Akshay S.
    Kober, Lars
    Packer, Milton
    Pfeffer, Marc A.
    Rouleau, Jean L.
    Sabatine, Marc S.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    Jhund, Pardeep S.
    McMurray, John J., V
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2998 - 3013
  • [3] Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?
    Ohte, Nobuyuki
    Little, William C.
    CIRCULATION JOURNAL, 2015, 79 (03) : 508 - 509
  • [4] Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction
    Srivaratharajah, Kajenny
    Coutinho, Thais
    deKemp, Robert
    Liu, Peter
    Haddad, Haissam
    Stadnick, Ellamae
    Davies, Ross A.
    Chih, Sharon
    Dwivedi, Girish
    Guo, Ann
    Wells, George A.
    Bernick, Jordan
    Beanlands, Robert
    Mielniczuk, Lisa M.
    CIRCULATION-HEART FAILURE, 2016, 9 (07)
  • [5] Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
    Carnicelli, Anthony P.
    Clare, Robert
    Hofmann, Paul
    Chiswell, Karen
    DeVore, Adam D.
    Vemulapalli, Sreekanth
    Felker, G. Michael
    Sarocco, Phil
    Mentz, Robert J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (17):
  • [6] Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction
    Bartko, Philipp E.
    Hulsmann, Martin
    Hung, Judy
    Pavo, Noemi
    Levine, Robert A.
    Pibarot, Philippe
    Vahanian, Alec
    Stone, Gregg W.
    Goliasch, Georg
    EUROPEAN HEART JOURNAL, 2020, 41 (29) : 2799 - +
  • [7] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [8] Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction
    Bello, Natalie A.
    Claggett, Brian
    Desai, Akshay S.
    McMurray, John J. V.
    Granger, Christopher B.
    Yusuf, Salim
    Swedberg, Karl
    Pfeffer, Marc A.
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2014, 7 (04) : 590 - 595
  • [9] Contemporary Trends in Heart Failure With Reduced and Preserved Ejection Fraction After Myocardial Infarction: A Community Study
    Gerber, Yariv
    Weston, Susan A.
    Berardi, Cecilia
    McNallan, Sheila M.
    Jiang, Ruoxiang
    Redfield, Margaret M.
    Roger, Veronique L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (08) : 1272 - 1280
  • [10] Curative effect analysis of urapidil on heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
    Yuan, Xiao-Ye
    Ding, Cun-Tao
    Li, Jing
    Tan, Jing
    Wang, Yan-Ling
    Fan, Zhen-Xing
    He, Jing-Yu
    Yang, Wei
    Hua, Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 494 - 503